Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nitric oxide during cardiopulmonary bypass in children undergoing congenital heart surgery
NL-OMON50652Phase 3Completed
- Sponsor
- University Medical Center Utrecht
- Start
- Feb 2019
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of nitric oxide in Cardiovascular Malformation (CVM), sponsored by University Medical Center Utrecht. Started Feb 2019; status: completed.
02
Drugs
nitric oxide
03
Conditions
Cardiovascular Malformation (CVM)
Beyond the preview
Go deeper on NL-OMON50652.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON50652.